Type 1 Diabetes FAQ
Type 1 Diabetes FAQ
Most of the questions that decide a medical journey are not medical. What does the programme cost and what does the stay involve? Which records actually matter? Is it safe to fly with a new diagnosis or a recently adjusted regimen? What happens to the treatment after the flight home? This page answers the practical set plainly, in the order families ask them, and keeps the medical answers where they belong — on the pages linked throughout.
What it costs
The initial assessment is free: records sent ahead are reviewed without charge, and the written opinion — including the eligibility verdict for the HIM protocol — comes back before any payment is discussed. Complete treatment in China typically runs at 30–50% of comparable care in Europe or the United States, across conditions and programmes. For the diabetes programme specifically, the components are the inpatient phase, the diagnostics that accompany it, and the follow-up platform; an itemised quotation is provided once the records define what is actually needed, because a patient whose antibodies and C-peptide already exist needs less than one whose type has never been settled.
How long the stay is
The inpatient phase of the protocol is three to five days. It is deliberately short: the intensive work — immune characterisation, protocol establishment, monitoring set-up — happens in that window, and the insulin regimen is restructured rather than abandoned, so discharge is to a working routine rather than to a cliff edge. Families commonly add a few days either side for travel and a settling visit; patients combining the programme with treatment for other conditions should plan around the longer episode, and the written plan states the total expected stay before booking.
Which records to send
Five items decide the assessment, and none requires translation beyond what our coordinators handle: the islet autoantibody panel with dates; the most recent C-peptide, and any earlier ones that show a trend; the HbA1c history; the current insulin regimen with doses; and the age at diagnosis with the presenting story. Where antibodies or C-peptide have never been measured, the opinion says so and states which two blood tests to arrange locally. Continuous glucose data exports, if they exist, are welcome; photographs of clinic letters are acceptable to start.
When travel is safe — and when it is not
Do not travel during suspected ketoacidosis or unstable, deteriorating control; after a severe hypoglycaemic episode, until the regimen has been reviewed; during an active infection or any illness that is pushing glucose and ketones up; or with a new diagnosis still in its first weeks of stabilisation, unless the programme team has reviewed the case and agreed a plan.
For everyone else, flying with diabetes is routine with three disciplines: insulin in hand luggage, never the hold — it freezes and thaws badly at altitude; twice as much of everything as the trip seems to need, split between two bags; and a doctor's letter covering the devices, since pumps and sensors meet security questions in every airport. Long flights add their own glucose noise — set an alarm on the sensor rather than trusting routine.
Insurance, direct billing and paperwork
We work with more than 30 commercial insurers on direct billing, and the coordinators confirm coverage, exclusions and the paperwork before arrival rather than after it. Patients without suitable coverage receive the itemised quotation and pay directly; either way, the costs are agreed in writing before travel. Discharge documents are issued in English, with the treatment summary written to be usable by a physician anywhere — diagnosis codes, regimens, and the monitoring plan in full.
What follows you home
The protocol is built for distance. Follow-up runs through the programme's tele-digital platform: continuous glucose data and scheduled immune-marker reviews are analysed continuously, and adjustments reach the patient wherever they are, which is the reason the inpatient phase can be as short as it is. Local follow-up still matters — an annual eye and kidney screen, thyroid checks, the childhood immunisations — and the discharge summary states which parts stay with the local physician and which continue with the programme, so the two never overlap or contradict.
Companions, language and the first conversation
One companion is welcome for the inpatient phase and matters more than families expect: the person who will run the sick-day plan at home should hear it explained in person. International medical liaison officers coordinate interpretation throughout, and the first conversation — the free records review — is available by video, which is the sensible first step for every family in this cluster: the eligibility question is answerable from records alone, and the journey only makes sense once that answer is in hand.